HuCD39 mAb-secreting MSLN CAR-T cells effectively inhibited tumor growth after infusion when MSLN CAR-T-cell therapy alone or CD19 CAR-T-cell therapy did not inhibit tumor growth (Figures 6D-E). The gene discussed is CD19; the disease is neoplasm.